Canada Life’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-717,846
Closed -$71.4M 2794
2019
Q3
$71.4M Buy
717,846
+71,535
+11% +$6.8M 0.17% 142
2019
Q2
$59.7M Sell
646,311
-25,003
-4% -$2.37M 0.14% 155
2019
Q1
$63.2M Buy
671,314
+122,234
+22% +$10.7M 0.17% 143
2018
Q4
$33.8M Buy
549,080
+10,639
+2% +$785K 0.1% 216
2018
Q3
$48.2M Sell
538,441
-126,465
-19% -$11.2M 0.11% 181
2018
Q2
$52.8M Sell
664,906
-19,539
-3% -$1.62M 0.12% 174
2018
Q1
$61.1M Sell
684,445
-50,469
-7% -$4.84M 0.15% 161
2017
Q4
$76.6M Sell
734,914
-26
-0% -$2.93K 0.18% 121
2017
Q3
$105M Sell
734,940
-31,960
-4% -$4.35M 0.26% 85
2017
Q2
$99.4M Buy
766,900
+178,797
+30% +$21.9M 0.27% 79
2017
Q1
$73.1M Sell
588,103
-30,455
-5% -$3.64M 0.2% 115
2016
Q4
$71.8M Sell
618,558
-32,881
-5% -$3.66M 0.2% 114
2016
Q3
$68.1M Buy
651,439
+69,618
+12% +$7.53M 0.2% 115
2016
Q2
$57.3M Buy
581,821
+131,071
+29% +$13.6M 0.17% 133
2016
Q1
$45.1M Sell
450,750
-79,787
-15% -$8.22M 0.16% 143
2015
Q4
$63.6M Buy
530,537
+22
+0% +$2.54K 0.24% 100
2015
Q3
$57.4M Sell
530,515
-206,287
-28% -$25.6M 0.23% 101
2015
Q2
$85.2M Sell
736,802
-135,784
-16% -$15.5M 0.29% 79
2015
Q1
$100M Sell
872,586
-10,481
-1% -$1.25M 0.34% 70
2014
Q4
$98.8M Sell
883,067
-27,312
-3% -$2.88M 0.33% 73
2014
Q3
$86.4M Buy
910,379
+15,275
+2% +$1.38M 0.29% 79
2014
Q2
$76.7M Buy
895,104
+18,130
+2% +$1.38M 0.25% 98
2014
Q1
$60.9M Buy
876,974
+63,408
+8% +$5.02M 0.21% 105
2013
Q4
$69M Sell
813,566
-149,926
-16% -$11.9M 0.24% 89
2013
Q3
$74.1M Buy
963,492
+365,990
+61% +$25.6M 0.29% 75
2013
Q2
$35M Buy
+597,502
New +$36M 0.23% 89

Other funds holding CELG

Canada Life's CELG Position: Q4 2019 in Review

Canada Life sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 717,846 shares — an estimated $71.4M sold.

Canada Life first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $105M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Canada Life reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Canada Life sold 717,846 Celgene Corp shares in Q4 2019, an estimated $71.4M.
  • Canada Life first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Canada Life's Celgene Corp position peaked at $105M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Canada Life's 13F filing for Q4 2019, filed 11 Feb 2020.